Parabilis Medicines Announces Strategic Collaboration with Regeneron Pharmaceuticals to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas

Parabilis Medicines today announced a strategic research collaboration with Regeneron Pharmaceuticals, Inc. to discover and develop multiple therapeutic candidates based on Parabilis’s Helicon™ ...
Yahoo Finance

HeliconNFT’s Official Launch as Helicon Studio Hosts an Immersive Blockchain & NFT Show with World-Renowned Experts at Blockchain World Abu Dhabi

ABU DHABI, United Arab Emirates, Dec. 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – HeliconNFT officially launches at Blockchain World, a playground for industry specialists, incorporating the ...
Pharmaceutical Technology on MSN

Regeneron signs $2.32BN deal with Parabilis for Helicon conjugates

Parabilis is set to receive $125m, including a $50m upfront payment and a $75m investment, subject to agreed conditions.
The New York Times

HELICON HALL HAS TAKEN TO BLOOMERS; Likewise Air Baths for Babies, Masquerade Parties, and, at Last -- Servants. NO PLACE FOR THE PRIM Therefore None Are Admitted and None Are ...

New York Times subscribers* enjoy full access to TimesMachine—view over 150 years of New York Times journalism, as it originally appeared. *Does not include Games-only or Cooking-only subscribers.

Parabilis Medicines Starts IPO On Promising Cancer Therapy Trials

Parabilis Medicines, Inc.’s IPO spotlights Helicon peptide cancer drugs like zolucatetide, plus Regeneron’s $125M backing & ...